Meta Growth (CVE:META) and Delta 9 Cannabis (TSE:DN) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, analyst recommendations and institutional ownership.
Earnings & Valuation
This table compares Meta Growth and Delta 9 Cannabis' top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Meta Growth | C$60.96 million | 0.54 | C$-50,412,840.00 | C($0.21) | -0.66 |
Delta 9 Cannabis | C$52.05 million | 1.14 | C$-7,346,808.00 | C($0.07) | -8.06 |
Delta 9 Cannabis has lower revenue, but higher earnings than Meta Growth. Delta 9 Cannabis is trading at a lower price-to-earnings ratio than Meta Growth, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Meta Growth and Delta 9 Cannabis, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Meta Growth | 0 | 0 | 0 | 0 | N/A |
Delta 9 Cannabis | 0 | 0 | 0 | 1 | 4.00 |
Delta 9 Cannabis has a consensus target price of C$1.10, suggesting a potential upside of 89.66%. Given Delta 9 Cannabis' higher probable upside, analysts clearly believe Delta 9 Cannabis is more favorable than Meta Growth.
Profitability
This table compares Meta Growth and Delta 9 Cannabis' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Meta Growth | N/A | N/A | N/A |
Delta 9 Cannabis | N/A | N/A | N/A |
Summary
Delta 9 Cannabis beats Meta Growth on 5 of the 7 factors compared between the two stocks.